Skip to content

Effects of High-intensity Interval Training in Patients in Hemodialysis

Effects of High-intensity Interval Training in Patients in Hemodialysis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01728415
Acronym
OsloExDia
Enrollment
18
Registered
2012-11-19
Start date
2012-10-31
Completion date
2016-09-30
Last updated
2014-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Renal Disease

Keywords

Exercise, Hemodialysis, Physical therapy, high-intensity

Brief summary

The purpose of this study is to evaluate the effects of high intensity interval training compared to moderate exercise training and a control group on exercise capacity and quality of life in patients with end stage renal disease on hemodialysis.

Interventions

OTHERexercise

Group A: high intensity exercise training Group B: moderate intensity exercise training C: Control group

Sponsors

Norwegian Fund for Postgraduate Training in Physiotherapy
CollaboratorOTHER
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients on hemodialysis ≥ 3 months

Exclusion criteria

* Acute infection * Systolic BP\>180 mmHG or diabolic BP\>105 mmHG * Unstable angina pectoris * Serious rhythm disturbances * Hyperkalemic (\> 6 mmol/L), * Unstable diabetes mellitus * Wheelchair * Dialyses access on lower extremities * Haemoglobin \< 9 g/dl

Design outcomes

Primary

MeasureTime frameDescription
Peak oxygen uptakebaseline, 16 weeksCanges from baseline in peak oxygen uptake at 16 weeks

Countries

Norway

Contacts

Primary ContactBirgitta Blakstad Nilsson, PhD
b.b.nilsson@medisin.uio.no+4793210913
Backup ContactAud Eldrid Stenehjem, PhD
uxaust@ous-hf.no+4790667069

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026